Activity and expression of vitamin K-dependent gamma-glutamyl carboxylase in patients with calcium oxalate urolithiasis

Urologia Internationalis

Volumn 85, Issue 1, 2010, Pages 94-99

  Wang, Tao ^a   Yang, Jun ^a   Qiao, Jiankun ^a   Liu, Jihong ^a   Guo, Xiaolin ^a   Ye, Zhangqun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Calcium oxalate urolithiasis; Gamma carboxyglutamic acid; Vitamin K dependent gamma glutamyl carboxylase

Indexed keywords

CALCIUM OXALATE; MESSENGER RNA; RNA DIRECTED DNA POLYMERASE; VITAMIN K DEPENDENT CARBOXYLASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; HYDRONEPHROSIS; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; KIDNEY CORTEX; KIDNEY PARENCHYMA; KIDNEY TUBULE EPITHELIUM; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UROLITHIASIS; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CALCIUM OXALATE; CARBON-CARBON LIGASES; CASE-CONTROL STUDIES; CHINA; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; MALE; MIDDLE AGED; NEPHRECTOMY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UROLITHIASIS;

EID: 77955715769     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000300570     Document Type: Article

References (23)

1. Watts RW: Idiopathic urinary stone disease: possible polygenic aetiological factors. QJM 2005; 98: 241-246.
2. Baumann JM, Affolter B, Caprez U, Clivaz C, Glück Z, Weber R: Stabilization of calcium oxalate suspension by urinary macromolecules, probably an efficient protection from stone formation. Urol Int 2007; 79: 267-272.
3. Stapleton AM, Dawson CJ, Grover PK, et al: Further evidence linking urolithiasis and blood coagulation: urinary prothrombin fragment 1 is present in stone matrix. Kidney Int 1996; 49: 880-888.
4. Stapleton A, Timme T, Ryall R: Gene expression of prothrombin in the human kidney and its potential relevance to kidney stone disease. Br J Urol 1998; 81: 666-671.
5. Grover PK, Ryall RL: Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity. Eur J Biochem 1999; 263: 50-56.
6. Liu J, Wang T, Chen J, et al: Decreased inhibitory activity of prothrombin to calcium oxalate crystallization by specific chemical modification of its gamma-carboxyglutamic acid residues. Urology 2006; 67: 201-203.
7. Liu J, Chen J, Wang T, et al: Effects of urinary prothrombin fragment 1 in the formation of calcium oxalate calculus. J Urol 2005; 173: 113-116.
8. Furie B, Bouchard BA, Furie BC: Vitamin Kdependent biosynthesis of gamma-carboxyglutamic acid. Blood 1999; 93: 1798-1808.
9. Chen J, Liu J, Zhang Y, et al: Decreased renal vitamin K-dependent gamma-glutamyl carboxylase activity in calcium oxalate calculi patients. Chin Med J (Engl) 2003; 116: 569-572.
10. Qiao J, Wang T, Yang J, Liu J, Gong X, Guo X, Wang S, Ye Z: Genetic mutation of vitamin K-dependent gamma-glutamyl carboxylase domain in patients with calcium oxalate urolithiasis. J Huazhong Univ Sci Technolog Med Sci 2009; 29: 604-608.
11. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods 2001; 25: 402-408.
12. Friedman PA, Mitch WE, Silva P: Localization of renal vitamin K-dependent gammaglutamyl carboxylase to tubule cells. J Biol Chem 1982; 257: 11037-11040.
13. Berkner KL, McNally BA: Purification of vitamin K-dependent carboxylase from cultured cells. Methods Enzymol 1997; 282: 313-333.
14. Angayarkanni N, Selvam R: Enhanced renal vitamin-K-dependent gamma-glutamyl carboxylase activity in experimental rat urolithiasis. Eur Urol 1998; 33: 116-120.
15. Leslie YC, Niclas E, Rhian G, et al: Gammaglutamyl carboylase (GGCX) micro-satellite and warfarin dosing. Blood 2005; 106: 3673-3674.
16. Wadelius M, Chen LY, Downes K, et al: Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Pharmacogenomics J 2005; 5: 262-270.
17. Pei-Chieng C, Taisei M, Atsushi T, et al: High-resolution SNP and haplotype maps of the human gamma-glutamyl carboxylase gene (GGCX) and association study between polymorphisms in GGCX and the warfarin maintenance dose requirement of the Japanese population. J Hum Genet 2007; 52: 856-864.
18. Hiroyuki K, Kimie N, Keinichiro N, et al: A functional single nucleotide poly-morphism in the vitamin-K-dependent gamma-glutamyl carboxylase gene (Arg325Gln) is associated with bone mineral density in elderly Japanese women. Bone 2007; 40: 451-456.
19. Spronk HM, Farah RA, Buchanan GR, et al: Novel mutation in the gamma-glutamyl carboxylase gene resulting in congenital combined deficiency of all vitamin K-dependent blood coagulation factors. Blood 2000; 96: 3650-3652.
20. Rost S, Geisen C, Fregin A, et al: Founder mutation Arg485Pro led to recurrent compound heterozygous GGCX genotypes in two German patients with VKCFD type 1. Blood Coagul Fibrinolysis 2006; 17: 503-507.
21. Furie B, Bouchard BA, Furie BC: Vitamin Kdependent biosynthesis of gamma-carboxyglutamic acid. Blood 1999; 93: 1798-1808.
22. Chen DH, Kaung HL, Miller CM, et al: Microarray analysis of changes in renal phenotype in the ethylene glycol rat model of urolithiasis: potential and pitfalls. BJU Int 2004; 94: 637-650.
23. Grover PK, Miyazawa K, Coleman M, et al: Renal prothrombin mRNA is significantly decreased in a hyperoxaluric rat model of nephrolithiasis. J Pathol 2006; 210: 273-281.